Luke V Blakeway
Overview
Explore the profile of Luke V Blakeway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen H, Peleg A, Song J, Antony B, Webb G, Wisniewski J, et al.
mSystems
. 2024 Aug;
9(9):e0078924.
PMID: 39150244
Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) is widely used in clinical microbiology laboratories for bacterial identification but its use for detection of antimicrobial resistance (AMR) remains limited....
2.
Macesic N, Dennis A, Hawkey J, Vezina B, Wisniewski J, Cottingham H, et al.
Infect Control Hosp Epidemiol
. 2024 Feb;
45(6):709-716.
PMID: 38344902
Objectives: New Delhi metallo-β-lactamases (NDMs) are major contributors to the spread of carbapenem resistance globally. In Australia, NDMs were previously associated with international travel, but from 2019 we noted increasing...
3.
Macesic N, Hawkey J, Vezina B, Wisniewski J, Cottingham H, Blakeway L, et al.
Nat Commun
. 2023 Aug;
14(1):4764.
PMID: 37553339
Infections caused by metallo-beta-lactamase-producing organisms (MBLs) are a global health threat. Our understanding of transmission dynamics and how MBLs establish endemicity remains limited. We analysed two decades of bla evolution...
4.
Mossop M, Robinson L, Jiang J, Peleg A, Blakeway L, Macesic N, et al.
J Med Microbiol
. 2023 Jun;
72(6).
PMID: 37289488
One third of people with CF in the UK are co-infected by both and . Chronic bacterial infection in CF contributes to the gradual destruction of lung tissue, and eventually...
5.
Loftus M, Young-Sharma T, Lee S, Wati S, Badoordeen G, Blakeway L, et al.
J Glob Antimicrob Resist
. 2022 Jun;
30:286-293.
PMID: 35738385
Objectives: There are scant primary clinical data on antimicrobial resistance (AMR) burden from low- and middle-income countries (LMICs). We adapted recent World Health Organization methodology to measure the effect of...
6.
Loftus M, Young-Sharma T, Wati S, Badoordeen G, Blakeway L, Byers S, et al.
Lancet Reg Health West Pac
. 2022 Apr;
22:100438.
PMID: 35373162
Background: bacteraemia (SAB) is one of the commonest bloodstream infections globally and is associated with a high mortality rate. Most published data comes from temperate, high-income countries. We describe the...
7.
Macesic N, Blakeway L, Stewart J, Hawkey J, Wyres K, Judd L, et al.
Clin Microbiol Infect
. 2021 Apr;
27(12):1856.e7-1856.e13.
PMID: 33915285
Objectives: mcr-9.1 is a newly described mobile colistin resistance gene. We have noted its presence in multiple species of carbapenem-resistant Enterobacterales (CRE) from our institution. We aimed to determine the...
8.
Tan A, Blakeway L, Taha , Yang Y, Zhou Y, Atack J, et al.
PLoS One
. 2020 Jun;
15(6):e0234306.
PMID: 32555615
Moraxella catarrhalis is a human-adapted, opportunistic bacterial pathogen of the respiratory mucosa. Although asymptomatic colonization of the nasopharynx is common, M. catarrhalis can ascend into the middle ear, where it...
9.
Blakeway L, Tan A, Peak I, Atack J, Seib K
Microbiol Resour Announc
. 2020 Apr;
9(14).
PMID: 32241868
is a leading bacterial cause of otitis media and exacerbations of chronic obstructive pulmonary disease. Here, we announce a transcriptome RNA sequencing data set detailing global gene expression in two...
10.
Blakeway L, Tan A, Peak I, Atack J, Seib K
Microbiol Resour Announc
. 2020 Mar;
9(12).
PMID: 32193234
is a leading cause of otitis media and exacerbations of chronic obstructive pulmonary disease; however, its response to iron starvation during infection is not completely understood. Here, we announce a...